SCHEMBL4197491

SCHEMBL4197491

N#CCC1C=CN=C(OCc2ccc(Cl)c(Cl)c2)N1c1nc2ccccc2s1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 3/20 0.38
PTGS1 P23219 3/20 0.37
PTGS2 P35354 3/20 0.37
ALOX5 P09917 3/20 0.37
ALDH1A1 P00352 2/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
S1PR2 O95136 1/20 0.36
GAA P10253 1/20 0.36
HPGD P15428 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36
TDP1 Q9NUW8 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
NPC1 O15118 3/20 0.34
CYP2C19 P33261 2/20 0.34
EPHX2 P34913 3/20 0.33
IDO1 P14902 1/20 0.33
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
CCR1 P32246 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4190547 0.89 MAPK9 (0.39) CYP2D6PTGS1PTGS2ALDH1A1MAPT
SCHEMBL7707665 0.87 NAAA (0.39) CYP2D6PTGS1PTGS2MAPTKDM4E
SCHEMBL4203404 0.86 PTGS1 (0.36) CYP2D6PTGS1PTGS2ALDH1A1MAPT
Acetonitrile SCHEMBL7707450 0.86 MAPK9 (0.38) CYP2D6PTGS1PTGS2ALDH1A1MAPT
SCHEMBL7707443 0.86 RAB9A (0.44) PTGS1PTGS2ALDH1A1MAPTKDM4E
SCHEMBL4197321 0.85 RAB9A (0.49) CYP2D6PTGS1PTGS2ALDH1A1MAPT
SCHEMBL5613992 0.85 PTGS1 (0.36) CYP2D6PTGS1PTGS2L3MBTL1NPC1
SCHEMBL4190537 0.85 MAPK8 (0.49) CYP2D6PTGS1PTGS2ALDH1A1MAPT
SCHEMBL4200032 0.84 LTA4H (0.45) CYP2D6PTGS1PTGS2ALDH1A1MAPT
SCHEMBL4193807 0.84 PTGS1 (0.35) CYP2D6PTGS1PTGS2KDM4ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2026802-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES Laboratoires Serono SA (CH) 2009-02-25 EP disclosed
WO-2007141224-A2 JNK INHIBITORS FOR TREATMENT OF SKIN DISEASES LABORATOIRES SERONO SA (CH) 2007-12-13 WO disclosed
EP-1240164-A1 BENZAZOLE DERIVATIVES AND THEIR USE AS JNK MODULATORS Applied Research Systems ARS Holding N.V. (AN) 2002-09-18 EP disclosed
WO-2001047920-A1 BENZAZOLE DERIVATIVES AND THEIR USE AS JNK MODULATORS APPLIED RESEARCH SYSTEMS ARS HOLDING N.V. (AN) 2001-07-05 WO disclosed